http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2188419-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75bd563172f2fefacc7887cbd9286efc
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
filingDate 2000-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f15e1808ee43ca30783075814ade28b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e9d5197496e19fb0491b05de7e6a82f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2105140715475d5dd5413bf770c3e7a
publicationDate 2002-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2188419-C2
titleOfInvention Method for studying anti-aggregation action of preparations by determining blood platelet aggregation in vitro
abstract FIELD: medicine. SUBSTANCE: method involves taking blood sample, stabilizing the sample, separating plasma reach in blood platelets by means of centrifuging, adding anti-aggregation agent, mixing and incubating plasma with and without the preparation at 36.5-37.5 C. Test system having anti-aggregation preparations of various mechanisms anti- aggregation activity with respect to blood platelets is applied. Preparation concentration in the test system is selected starting from the taken single dose. Blood platelets aggregation level index is to be determined before and after introducing the anti-aggregation preparation as adenosine diphosphate-induced blood platelets aggregation. Adenosine diphosphate-induced blood platelets aggregation of a preparation being by 50% and more different from the control sample, the preparation is considered to be efficient. EFFECT: enhanced effectiveness in individually selecting preparations.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2486523-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2499261-C1
priorityDate 2000-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407866699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527521
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2PG45
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2KIG5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9DBX6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502323
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ96SQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536192
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47787
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1LIA5

Total number of triples: 39.